3.0600
-0.3250
(-9.60%)
At close: January 10 at 4:00:02 PM EST
3.0700
+0.01
+(0.33%)
After hours: January 10 at 4:29:35 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.61M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LAWLOR AUGUSTINE Chief Operating Officer | Conversion of Exercise of derivative security at price 2.82 per share. | Indirect | 6,024 | Nov 13, 2024 |
| CAVANAUGH JAMES H Director | Conversion of Exercise of derivative security at price 2.82 per share. | Direct | 601 | Nov 13, 2024 |
| MIRABELLI CHRISTOPHER K Chairman of the Board | Conversion of Exercise of derivative security at price 2.82 per share. | Indirect | 6,024 | Nov 13, 2024 |
| ONSI DOUGLAS E Chief Executive Officer | Conversion of Exercise of derivative security at price 2.82 per share. | Indirect | 6,024 | Nov 13, 2024 |
| LAWLOR AUGUSTINE Chief Operating Officer | -- | Direct | -- | Jan 26, 2024 |
| MIRABELLI CHRISTOPHER K Chairman of the Board | -- | Direct | -- | Jan 26, 2024 |
| ONSI DOUGLAS E Chief Executive Officer | -- | Direct | -- | Jan 26, 2024 |
| SIRARD CYNTHIA M.D. Officer | -- | Direct | -- | Jan 26, 2024 |
| O'MAHONY JOHN MARK Officer | -- | Direct | -- | Jan 26, 2024 |
| ONSI DOUGLAS E Chief Executive Officer | -- | Direct | -- | Mar 17, 2023 |
Related Tickers
CRVS Corvus Pharmaceuticals, Inc.
5.33
-5.66%
MREO Mereo BioPharma Group plc
3.5500
-5.59%
CLSD Clearside Biomedical, Inc.
0.9800
+0.74%
AFMD Affimed N.V.
1.1800
-0.84%
CDTX Cidara Therapeutics, Inc.
24.00
-3.54%
PDSB PDS Biotechnology Corporation
1.4100
-10.19%
PXMD PaxMedica, Inc.
0.0580
-10.77%
ADIL Adial Pharmaceuticals, Inc.
1.0200
-0.97%
SWTX SpringWorks Therapeutics, Inc.
43.00
+6.20%
ALXO ALX Oncology Holdings Inc.
1.7700
-4.32%